Cargando…

The p53 challenge of hematopoietic stem cell gene editing

Ex vivo gene editing in hematopoietic stem and progenitor cells (HSPCs) represents a promising curative treatment strategy for monogenic blood disorders. Gene editing using the homology-directed repair (HDR) pathway enables precise genetic modifications ranging from single base pair correction to re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dorset, Sofie R., Bak, Rasmus O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331021/ https://www.ncbi.nlm.nih.gov/pubmed/37435043 http://dx.doi.org/10.1016/j.omtm.2023.06.003

Ejemplares similares

Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing
por: Anurogo, Dito, et al.
Publicado: (2021)

Advances and Obstacles in Homology-Mediated Gene Editing of Hematopoietic Stem Cells
por: Salisbury-Ruf, Christi T., et al.
Publicado: (2021)

Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response
por: Schiroli, Giulia, et al.
Publicado: (2019)

Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease
por: Germino-Watnick, Paula, et al.
Publicado: (2022)

Roles of p53 in Various Biological Aspects of Hematopoietic Stem Cells
por: Nii, Takenobu, et al.
Publicado: (2012)

Homology-directed gene-editing approaches for hematopoietic stem and progenitor cell gene therapy
por: Azhagiri, Manoj Kumar K., et al.
Publicado: (2021)

Therapy Development by Genome Editing of Hematopoietic Stem Cells
por: Koniali, Lola, et al.
Publicado: (2021)

Enrichment strategies to enhance genome editing
por: Mikkelsen, Nanna S., et al.
Publicado: (2023)

Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I
por: Gomez-Ospina, Natalia, et al.
Publicado: (2019)

Current approaches and potential challenges in the delivery of gene editing cargos into hematopoietic stem and progenitor cells
por: Murugesan, Ramya, et al.
Publicado: (2023)

In Vivo Hematopoietic Stem Cell Genome Editing: Perspectives and Limitations
por: Psatha, Nikoletta, et al.
Publicado: (2022)

Highly efficient therapeutic gene editing of human hematopoietic stem cells
por: Wu, Yuxuan, et al.
Publicado: (2019)

Hematopoietic stem and progenitors cells gene editing: Beyond blood disorders
por: Buffa, Valentina, et al.
Publicado: (2023)

Hematopoietic Stem Cell Transplantation in Egypt: Challenges and Opportunities
por: Mahmoud, H.K., et al.
Publicado: (2020)

Genome editing of donor-derived T cells to generate allogeneic chimeric antigen receptor-modified T cells: optimizing αβ T-cell-depleted haploidentical hematopoietic stem cell transplantation
por: Wiebking, Volker, et al.
Publicado: (2020)

Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation
por: Ferrari, Samuele, et al.
Publicado: (2021)

P1373: UNCOVERING UPSIDES AND PITFALLS OF BASE AND PRIME EDITING IN HEMATOPOIETIC STEM CELLS
por: Fiumara, Martina, et al.
Publicado: (2023)

Controlling genetic heterogeneity in gene-edited hematopoietic stem cells by single-cell expansion
por: Becker, Hans Jiro, et al.
Publicado: (2023)

An RPS19-edited model for Diamond-Blackfan anemia reveals TP53-dependent impairment of hematopoietic stem cell activity
por: Bhoopalan, Senthil Velan, et al.
Publicado: (2023)

The Ongoing Challenge of Hematopoietic Stem Cell-Based Gene Therapy for β-Thalassemia
por: Drakopoulou, Ekati, et al.
Publicado: (2011)

Priming Human Repopulating Hematopoietic Stem and Progenitor Cells for Cas9/sgRNA Gene Targeting
por: Charlesworth, Carsten T., et al.
Publicado: (2018)

Clinically relevant gene editing in hematopoietic stem cells for the treatment of pyruvate kinase deficiency
por: Fañanas-Baquero, Sara, et al.
Publicado: (2021)

Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells
por: Omer-Javed, Attya, et al.
Publicado: (2022)

Therapeutic adenine base editing of human hematopoietic stem cells
por: Liao, Jiaoyang, et al.
Publicado: (2023)

Targeted Genome Editing in Human Repopulating Hematopoietic Stem Cells
por: Genovese, Pietro, et al.
Publicado: (2014)

Transient inhibition of p53 enhances prime editing and cytosine base-editing efficiencies in human pluripotent stem cells
por: Li, Mu, et al.
Publicado: (2022)

p53-dependent induction of P2X7 on hematopoietic stem and progenitor cells regulates hematopoietic response to genotoxic stress
por: Tung, Lin Tze, et al.
Publicado: (2021)

Challenges of Gene Editing Therapies for Genodermatoses
por: Brooks, Imogen R., et al.
Publicado: (2023)

CRISPR/Cas-Based Gene Editing Strategies for DOCK8 Immunodeficiency Syndrome
por: Ravendran, Sujan, et al.
Publicado: (2022)

Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking
por: Ferrari, Samuele, et al.
Publicado: (2020)

CRISPR-Cas9 Gene Editing of Hematopoietic Stem Cells from Patients with Friedreich’s Ataxia
por: Rocca, Celine J., et al.
Publicado: (2020)

Functions of p53 in pluripotent stem cells
por: Fu, Xuemei, et al.
Publicado: (2019)

Challenges of CRISPR-Based Gene Editing in Primary T Cells
por: Rezalotfi, Alaleh, et al.
Publicado: (2022)

Cell-Cycle-Specific Function of p53 in Fanconi Anemia Hematopoietic Stem and Progenitor Cell Proliferation
por: Li, Xiaoli, et al.
Publicado: (2018)

Amniotic Fluid Cells, Stem Cells, and p53: Can We Stereotype p53 Functions?
por: Rodrigues, Melissa, et al.
Publicado: (2019)

No apparent p53 activation in CRISPR‐engineered gene‐edited rabbits
por: Zhang, Tao, et al.
Publicado: (2021)

Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6
por: Bak, Rasmus O, et al.
Publicado: (2017)

Inhibition of p53-Dependent, but Not p53-Independent, Cell Death by U19 Protein from Human Herpesvirus 6B
por: Kofod-Olsen, Emil, et al.
Publicado: (2013)

Correction: Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6
por: Bak, Rasmus O, et al.
Publicado: (2018)

Adipose Derived Stem Cells Affect miR-145 and p53 Expressions of Co-Cultured Hematopoietic Stem Cells
por: Foroutan, Tahereh, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hcmiep0s7dlpeh6l2nve3psb85